SOX2 and breast cancer: The findings of this study revealed decreased expression of β-catenin, Oct4, Sox2, Snail1, and the subsequent increased expression of E-cadherin by rBmK AGAP both in vitro and in vivo which to reduce breast cancer cell stemness and epithelial-mesenchymal transition.